Found 1 publication.
Displayed publication 1
Expand all publications
Collapse all publications
Show all as text (SweetDB notation)
Show all graphically (SNFG notation)
1. (Article ID: 2663)
Burroughs MH, Chang YS, Gage DA, Tuomanen EI
Composition of the peptidoglycan of Haemophilus influenzae
Journal of Biological Chemistry 268 (1993)
11594-11598
The composition of the peptidoglycan of Haemophilus influenzae was determined by analyzing glycopeptides generated by M1 muramidase hydrolysis using high pressure liquid chromatography, fast atom bombardment mass spectrometry, and fast atom bombardment collisionally activated dissociation tandem mass spectrometry, and amino acid analysis. The structures of 17 glycopeptides, representing 96% of the total peptidoglycan, were ascertained. Fifteen glycopeptides resembled species described for Escherichia coli peptidoglycan (Glauner, B., and Schwarz, U. (1983) The Target of Penicillin (Hackenbeck, R., ed), Walter de Gruyter, Berlin pp. 29-34) as compared with 9 in common with Bordetella pertussis (Tuomanen, E., Schwartz, J., Sande, S., Light, K., and Gage, D. (1989) J. Biol. Chem. 264, 11093-11098). Substitutions for L-alanine in the fourth position of the stem peptide included glycine, aspartic acid, and serine. The peptidoglycan was 27% cross-linked, 2% of which formed between diaminopimelic acid residues. No species was identified containing lysyl-arginine residues characteristic of lipoprotein. The peptidoglycan of non-β-lactamase-mediated antibiotic-resistant H. influenzae differed from that of sensitive strains by an increase in the amount of disaccharide tripeptides and a decrease in 1,6-anhydro dimers. Both changes were transformable properties that changed in a stepwise fashion in parallel with the degree of antibiotic resistance.
NCBI PubMed ID: 8505290Journal NLM ID: 2985121RPublisher: Baltimore, MD: American Society for Biochemistry and Molecular Biology
Institutions: Laboratory of Molecular Infectious Diseases, Rockefeller University, New York, New York 10021
Methods: FAB-MS, HPLC, FAB-CID-MS/MS
The publication contains the following compound(s):
- Compound ID: 5972
Structure type: oligomer
; 872 [M+H]
Compound class: peptidoglycan
Reference(s) to other database(s): CCSD:
33861
- Compound ID: 5973
|
b-D-GlcpNAc-(1-4)-+
|
Asp-(2-1)-PmN2-(2-5)-Glu-(2-1)-Ala-(2-8)-Murp2Ac |
Show graphically |
Structure type: oligomer
; 986 [M+H]
Compound class: peptidoglycan
Reference(s) to other database(s): CCSD:
38271
- Compound ID: 5974
|
b-D-GlcpNAc-(1-4)-+
|
Ser-(2-1)-PmN2-(2-5)-Glu-(2-1)-Ala-(2-8)-Murp2Ac |
Show graphically |
Structure type: oligomer
; 960 [M+H]
Compound class: peptidoglycan
Reference(s) to other database(s): CCSD:
38272
- Compound ID: 5975
|
b-D-GlcpNAc-(1-4)-+
|
Gly-(2-1)-PmN2-(2-5)-Glu-(2-1)-Ala-(2-8)-Murp2Ac |
Show graphically |
Structure type: oligomer
; 929 [M+H]
Trivial name: muramyl peptide
Compound class: peptidoglycan
Reference(s) to other database(s): CCSD:
38273
- Compound ID: 5976
|
b-D-GlcpNAc-(1-4)-+
|
Ala-(2-1)-PmN2-(2-5)-Glu-(2-1)-Ala-(2-8)-Murp2Ac |
Show graphically |
Structure type: oligomer
; 940-942 [M+H]
Compound class: peptidoglycan
Reference(s) to other database(s): CCSD:
38274
- Compound ID: 6749
|
Ala-(1-6)-+
|
b-D-GlcpNAc-(1-4)-Mur2Ac-(8-2)-Ala-(1-2)-Glu-(5-2)-PmN2-(?-2)-+
|
Ala-(1-6)-+ | b-D-GlcpNAc-(1-4)-+
| | |
b-D-GlcpNAc-(1-4)-Mur2Ac-(8-2)-Ala-(1-2)-Glu-(5-2)-PmN2-(?-2)-Ala-(1-2)-PmN2-(6-5)-Glu-(2-1)-Ala-(2-8)-b-Murp2Ac |
Show graphically |
Structure type: oligomer
; 2791
Compound class: peptidoglycan
- Compound ID: 6750
|
b-D-GlcpNAc-(1-4)-Murp2Ac-(8-2)-Ala-(1-2)-Glu-(5-2)-PmN2-(1-2)-+
|
b-D-GlcpNAc-(1-4)-1,6anhMurp2Ac-(8-2)-Ala-(1-2)-Glu-(5-2)-PmN2-(6-1)-Ala |
Show graphically |
Structure type: oligomer
; 1776
Compound class: peptidoglycan
- Compound ID: 6751
|
b-D-GlcpNAc-(1-4)-1,6anhMurp2Ac-(8-2)-Ala-(1-2)-Glu-(5-2)-PmN2-(6-1)-+
|
Ala-(?-?)-+ |
| |
b-D-GlcpNAc-(1-4)-Murp2Ac-(8-2)-Ala-(1-2)-Glu-(5-2)-PmN2-(1-2)-Ala |
Show graphically |
Structure type: oligomer
; 1847
Compound class: peptidoglycan
- Compound ID: 6752
|
Ala-(?-?)-+
|
b-D-GlcpNAc-(1-4)-Mur2Ac-(8-2)-Ala-(1-2)-Glu-(5-2)-PmN2-(?-2)-+
|
Ala-(?-?)-+ | b-D-GlcpNAc-(1-4)-+
| | |
b-D-GlcpNAc-(1-4)-Mur2Ac-(8-2)-Ala-(1-2)-Glu-(5-2)-PmN2-(?-2)-Ala-(1-2)-PmN2-(6-5)-Glu-(2-1)-Ala-(2-8)-b-1,6anhMurp2Ac |
Show graphically |
Structure type: oligomer
; 2771
Compound class: peptidoglycan
- Compound ID: 10063
|
b-D-GlcpNAc-(1-4)-Murp-(8-2)-Ala-(1-2)-Glu-(5-2)-+
|
b-D-GlcpNAc-(1-4)-Murp-(8-2)-Ala-(1-2)-Glu-(5-2)-PmN2-(1-2)-Ala-(1-6)-PmN2 |
Show graphically |
Structure type: oligomer
; 1796
Compound class: peptidoglycan
Reference(s) to other database(s): CCSD:
38275, CBank-STR:13708
- Compound ID: 10064
|
b-D-GlcpNAc-(1-4)-Murp-(8-2)-Ala-(1-2)-Glu-(5-2)-+
|
Gly-(2-7)-+ |
| |
b-D-GlcpNAc-(1-4)-Murp-(8-2)-Ala-(1-2)-Glu-(5-2)-PmN2-(1-2)-Ala-(1-6)-PmN2 |
Show graphically |
Structure type: oligomer
; 1853
Compound class: peptidoglycan
Reference(s) to other database(s): CCSD:
38276, CBank-STR:14148
- Compound ID: 10065
|
b-D-GlcpNAc-(1-4)-Murp-(8-2)-Ala-(1-2)-Glu-(5-2)-+
|
Ala-(2-7)-+ |
| |
b-D-GlcpNAc-(1-4)-Murp-(8-2)-Ala-(1-2)-Glu-(5-2)-PmN2-(1-2)-Ala-(1-6)-PmN2 |
Show graphically |
Structure type: oligomer
; 1862-1864
Compound class: peptidoglycan
Reference(s) to other database(s): CCSD:
38277, CBank-STR:14149
- Compound ID: 10066
|
b-D-GlcpNAc-(1-4)-Murp-(8-2)-Ala-(1-2)-Glu-(5-2)-+
|
Ala-(2-7)-+ |
| |
b-D-GlcpNAc-(1-4)-Murp-(8-2)-Ala-(1-2)-Glu-(5-2)-PmN2-(1-2)-Ala-(1-6)-PmN2
|
Ala-(2-7)-+ |
Show graphically |
Structure type: oligomer
; 1862
Compound class: peptidoglycan
Reference(s) to other database(s): CCSD:
38278, CBank-STR:14512
Expand this publication
Collapse this publication
Total list of publication IDs on all result pages of the current query:
Total list of corresponding CSDB IDs (permanent record IDs):
Execution: 4 sec